Please login to the form below
Healthcare terms - R
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare terms - R
- Random samplings
- Randomisation
- Randomised trial
- Range
- Rate card
- Reach
- Readership
- Recall test
- Recession
- Reciprocal links
- Recognition tests
- Recruiting
- Recruitment status
- Reference group
- Reference pricing
- Registered trademark
- Regression analysis
- Reimbursement
- Reinforcement advertising
- Relationship marketing
- Relative advantage
- Relative market share
- Repositioning
- Reprint
- Research and development (R&D)
- Research proposal
- Respondent
- Respondent fatigue
- Response bias
- Response rate
- Responsiveness
- Return on equity (ROE)
- Return on investment (ROI)/Return on capital employed (ROCE)
- Return on sales enablement (ROSE)
- Risk analysis
- Risk-benefit analysis
- Routine response behaviour
- Royal Pharmaceutical Society of Great Britain (RPSGB)
- RSS
COVID-19 Updates and Daily News
Featured jobs
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
SENIOR MEDICAL WRITER
-
Salary TBC
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
- Pfizer/BioNTech to develop a booster dose for their COVID-19 vaccine
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- AZ refutes reports suggesting its COVID-19 vaccine is less effective in the elderly
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- Novavax to provide 1.1 billon COVID-19 vaccine doses to COVAX
- Enabling Patient-Focused Research Through Virtual Clinical Trials
- Innovative Approaches to Managing Mental Health Conditions
- Newcells Biotech secures over £5m for 3D tissue models
- FDA briefing document backs J&J’s one-dose COVID-19 vaccine
- Pfizer/BioNTech vaccine is 94% effective after second dose, major real-world study finds
- Moderna announces plans for COVID-19 variant-specific booster jabs and new production targets
PMHub
KVA Digital
KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...
Quick links
Infographics
